The global clinical nutrition market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market during the forecast period includes the presence of the COVID-19 pandemic, which is expected to have a strong influence on the demand for clinical nutrition products, as the demand for nutritional management, particularly among children and the older population, continues to witness consistent growth. The demand for clinical nutrition products amid COVID-19 crisis has increased, as consumers were seeking for various immunity-boosting alternatives to prevent being infected by the novel coronavirus. At the onset of the pandemic, older people and patients are at risk of malnutrition. The infection also causes a lack of appetite, along with other symptoms such as anosmia dysgeusia, or diarrhea, both of which raise the risk of disease-related malnutrition. Acute malnutrition caused by COVID-19 infection led to increasing in loss of muscle mass and a deterioration of immune defenses, which in turn, is expected to fuel the growth of the global clinical nutrition market during the forecast period. The growth of the global clinical nutrition market is majorly driven by rise in prevalence of metabolic disorders and cancer.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/clinical-nutrition-market
Further, the growing number of elderly population and development of clinical nutrition products specific to ageing population is expected to drive the market growth. However, certain restraints such as lack of awareness for clinical medical nutrition and stringent regulations are hampering the growth of clinical nutrition. Clinical nutrition product is a type of pharmaceutical product that supports to keep a patient healthy. It supports to improve the metabolic system by providing adequate supplements such as minerals, vitamins, and others. Clinical nutrition treat diseases that affect the intake, intestinal absorption, and metabolism of constituents of the diet, and support promote health through the prevention of diet-related diseases. It works in both acute and ambulatory care settings, which includes cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Route of Administration
o By Application
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape: Abbott Laboratories, Nestlé S.A., and Danone S.A., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Clinical Nutrition Market Report by Segment
By Route of Administration
- Oral and Enteral
- Parenteral
By Application
- Malnutrition
- Metabolic Disorders
- Cancer
- Gastrointestinal Diseases
- Neurological Diseases
- Others
A full report of Clinical Nutrition Market is available at: https://www.omrglobal.com/industry-reports/clinical-nutrition-market
Clinical Nutrition Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Laboratories,
- Nestlé S.A.
- Danone S.A.
